NEJM· @NEJM · X·· 6 天前精选AI 评分58
AI 导读
NEJM公布的PEPPER试验显示,髋或膝关节置换术后用阿司匹林预防静脉血栓栓塞(VTE),在症状性VTE或死亡上未证明非劣于利伐沙班或华法林。华法林和利伐沙班在安全性上同样未证明非劣于阿司匹林。完整结果与配发评论已发布。
推荐理由
PEPPER试验同时检验疗效与安全性非劣效,结果未支持阿司匹林替代利伐沙班或华法林。
正文
A trial of venous thromboembolism (VTE) prophylaxis after hip or knee arthroplasty did not show that aspirin was noninferior to rivaroxaban or warfarin for symptomatic VTE or death. Warfarin and rivaroxaban were not noninferior to aspirin for safety. Full PEPPER trial results: https://nej.md/4iIxVL0
Editorial: Aspirin Therapy — Enough after Arthroplasty https://nej.md/3UoXzwn
来源:NEJM · x.com